Manatuck Hill Partners’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.8M Sell
49,428
-10,000
-17% -$2.22M 3.7% 4
2026
Q2
$12.6M Sell
59,428
-972
-2% -$178K 4.16% 3
2026
Q1
$9.6M Hold
60,400
– – 2.6% 4
2025
Q4
$8.28M Hold
60,400
– – 2.9% 10
2025
Q3
$7.34M Hold
60,400
– – 2.43% 11
2025
Q2
$6.46M Hold
60,400
– – 2.43% 10
2025
Q1
$5.61M Buy
+60,400
New +$5.85M 2.58% 11
2024
Q4
– Sell
-6,000
Closed -$755K – 137
2024
Q3
$755K Sell
6,000
-8,700
-59% -$1.09M 0.28% 83
2024
Q2
$1.59M Hold
14,700
– – 0.66% 45
2024
Q1
$1.39M Sell
14,700
-3,300
-18% -$312K 0.61% 48
2023
Q4
$1.66M Hold
18,000
– – 0.7% 42
2023
Q3
$1.15M Hold
18,000
– – 0.52% 52
2023
Q2
$1.11M Buy
18,000
+3,000
+20% +$178K 0.53% 54
2023
Q1
$871K Buy
+15,000
New +$862K 0.44% 51

Other funds holding NHC

Manatuck Hill Partners's NHC Position: Q3 2026 in Review

Manatuck Hill Partners reduced its National Healthcare (NHC) stake by 17% in Q3 2026, selling an estimated $2.22M and leaving 49,428 shares worth $10.8M. The position accounts for 3.7% of the portfolio, ranked #4.

Manatuck Hill Partners first reported a position in NHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $12.6M in Q2 2026. 273 funds tracked by Wall St. Rank hold NHC as of Q3 2026.

  • Manatuck Hill Partners held 49,428 shares of National Healthcare worth $10.8M as of Q3 2026.
  • Manatuck Hill Partners sold 10,000 National Healthcare shares in Q3 2026, an estimated $2.22M.
  • National Healthcare made up 3.7% of Manatuck Hill Partners's portfolio in Q3 2026, its #4 holding.
  • Manatuck Hill Partners first reported a position in National Healthcare in Q1 2023 and has held it in 14 quarters since.
  • Manatuck Hill Partners's National Healthcare position peaked at $12.6M in Q2 2026.
  • 273 funds tracked by Wall St. Rank held National Healthcare as of Q3 2026.

Based on Manatuck Hill Partners's 13F filing for Q3 2026, filed 16 Nov 2026.